Literature DB >> 23752487

Genome-wide hypomethylation and cancer risk--letter.

Adam R Karpf.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23752487      PMCID： PMC3836259          DOI： 10.1158/1940-6207.CAPR-13-0162

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN： 1940-6215


× No keyword cloud information.
  5 in total

1.  Specific method for the determination of genomic DNA methylation by liquid chromatography-electrospray ionization tandem mass spectrometry.

Authors:  Liguo Song; Smitha R James; Latif Kazim; Adam R Karpf
Journal:  Anal Chem       Date:  2005-01-15       Impact factor: 6.986

2.  Coordinated cancer germline antigen promoter and global DNA hypomethylation in ovarian cancer: association with the BORIS/CTCF expression ratio and advanced stage.

Authors:  Anna Woloszynska-Read; Wa Zhang; Jihnhee Yu; Petra A Link; Paulette Mhawech-Fauceglia; Golda Collamat; Stacey N Akers; Kelly R Ostler; Lucy A Godley; Kunle Odunsi; Adam R Karpf
Journal:  Clin Cancer Res       Date:  2011-02-04       Impact factor: 12.531

3.  High-throughput and cost-effective global DNA methylation assay by liquid chromatography-mass spectrometry.

Authors:  Xingnan Li; Adrian A Franke
Journal:  Anal Chim Acta       Date:  2011-07-19       Impact factor: 6.558

Review 4.  Is there a link between genome-wide hypomethylation in blood and cancer risk?

Authors:  Kevin Brennan; James M Flanagan
Journal:  Cancer Prev Res (Phila)       Date:  2012-11-07

5.  Association between global DNA hypomethylation in leukocytes and risk of breast cancer.

Authors:  Ji-Yeob Choi; Smitha R James; Petra A Link; Susan E McCann; Chi-Chen Hong; Warren Davis; Mary K Nesline; Christine B Ambrosone; Adam R Karpf
Journal:  Carcinogenesis       Date:  2009-07-07       Impact factor: 4.944
  5 in total
  1 in total

1.  LINE1 and Alu repetitive element DNA methylation in tumors and white blood cells from epithelial ovarian cancer patients.

Authors:  Stacey N Akers; Kirsten Moysich; Wa Zhang; Golda Collamat Lai; Austin Miller; Shashikant Lele; Kunle Odunsi; Adam R Karpf
Journal:  Gynecol Oncol       Date:  2013-12-25       Impact factor: 5.482
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.